ABSTRACT The murine immune interferon (IFN-y) gene was cloned and expressed under control of the simian virus 40 early promoter in the monkey COS-1 cell line. A protein is secreted from these cells having the biological, antigenic, and biochemical characteristics of natural murine IFN-y. Cloned murine IFN-y cDNAs were obtained by using RNA from both mitogen-induced murine spleens and the transfected COS cells, and both code for identical proteins. The mature murine IFN-y encoded is 136 amino acids long, 10 amino acids shorter than human IFN-y. The nucleotide homology between the murine and human IFN-y genes is 60-65%, whereas the encoded proteins are only 40% homologous. Murine IFN-y cDNA was expressed in Escherichia coli under trp promoter control.
IFN-y cDNA was expressed in Escherichia coli under trp promoter control.
Murine immune interferon (MuIFN-y) has been isolated from mitogen-induced mouse spleen cultures (1-4) and T-cell lines (5, 6) . These preparations have not been purified to homogeneity but nevertheless contain potent in vitro antiviral and anticellular activities (1) (2) (3) (4) (5) (6) . MuIFN-y may also have in vivo antitumor efficacy (7) .
We previously reported the isolation and expression of the cDNA (8) and gene (9) for human IFN-y (HuIFN-y). This gene encodes a protein of 166 amino acids; the first 20 residues serve as a signal sequence for the secreted, mature protein. HuIFN-'y is distinctly different from HuIFN-a (leukocyte IFN) and HuIFN-(3 (fibroblast IFN): HuIFN-y is encoded by a single gene on chromosome 12 (10) , which contains three introns (9) . The HuIFN-a gene family and single HuIFN-,B gene are encoded by chromosome 9 (11) and contain no introns (12) (13) (14) (15) (16) (17) . Furthermore, the DNA sequence and encoded amino acid sequence of HuIFN-y are unrelated to the HuIFN-a sequences (8, 12, 18) or the HuIFN-,B sequence (15) (16) (17) . Whereas HuIFNa and HuIFN-f3 generally exhibit some antiviral activity on cell lines of other species (19) , HuIFN-y has a strict species specificity. Consequently, murine model systems, which have been useful in the study of potential antitumor agents, may not be suitable for examination of HuIFN-y. Therefore, a source of MuIFN-y could prove to be quite valuable in murine model systems and may aid the evaluation of the clinical potential of HuIFN-y.
MuIFN-a (20) and MuIFN-,B (T. Taniguchi, personal communication) genes have recently been cloned and characterized. However, no structural data on MuIFN-y has been determined. The properties of MuIFN-y are similar in some respects to HuIFN-y; the antiviral activity of MuIFN-y is sensitive to pH 2 and temperature (65°C for 1 hr) (1, 2, 5) . Antibodies prepared against MuIFN-a or MuIFN-(3 do not neutralize MuIFN-y antiviral activity (3) (4) (5) . In an effort to determine the structure of MuIFN-y, to further characterize its properties, and to provide material for animal testing, we isolated the (21) . The probe was hybridized to a recombinant murine-A phage library (prepared from M600 murine genomic DNA in ACh4A, generously provided by C. Simonsen) essentially as described by Maniatis et al. (22) . Hybridization was performed at a low stringency in 20% formamide, and filters were washed twice in 0.3 M sodium chloride/0.03 M sodium citrate/0. 1% NaDodSO4 at room temperature. Several phage that hybridized with the probe were plaque-purified (22) . Phage DNA was prepared (22, 23) , digested with various restriction endonucleases, subjected to electrophoresis through 1% agarose gels, and analyzed with Southern blots (24) by hybridization with the human cDNA probe. The 10.5-kbp BamHI fragment from phage AMG9 that hybridized with the human cDNA was isolated by agarose gel electrophoresis, electroeluted, and subcloned into the BamHI site of pBR322 to yield the plasmid pmgl0.5. The sequence of >6,000 bp of the insert of pmgl0.5 was determined by a combination of the Maxam and Gilbert chemical degradation technique (25) and the dideoxy chain-termination method of Sanger and colleagues (26) .
Expression of the MuIFN-y Gene in Monkey Cells. The MuIFN-y gene was ligated into a simian virus 40 (SV40)-based expression vector as outlined in Fig. 1 . The endonuclease Pvu II cleaves the plasmid pmgl0.5 at six positions, one of which is in the 5' untranslated region (71 bp upstream of the ATG initiation codon) of the gene. The 5' end of the gene was isolated as a 348-bp fragment from this Pvu II site to a unique Cla I site in the first intron. The 3' end of the MuIFN-y gene was isolated as a 6,400-bp Cla I-Bgl II fragment. The expression vector is derived from the plasmid p342E (27) 48 hr after transfection and assayed for antiviral activity in a cytopathic effect inhibition assay (19) with encephalomyocarditis virus as a challenge virus and murine L929 cells as the target. The assay was standardized against MuIFN-a and MuIFN-f3 of known activity (Lee Biomolecular Laboratories, San Diego, CA).
Isolation of MuIFN-y cDNA Clones from Transfected COS-1 Cells and Murine Spleens. RNA was isolated by the method of Berger and Birkenmeier (29) from COS-1 cells 48 hr after transfection with the MuIFN-y expression plasmid pSVEmuy or from concanavalin A-induced (30) spleen cells from CD1 mice after a 24-hr induction. The purified RNAs were passed over oligo(dT)-cellulose to enrich for mRNA. Double-stranded cDNA was prepared from 5 jig of each mRNA and cloned in E. coli by standard procedures (31) . Transformants were screened by using the 3' end of the MuIFN-y gene as a probe (800-bp Pst I fragment containing the entire fourth exon).
Expression of MuIFN-ycDNA inE. coli. A MuIFN-ycDNA (pmcl4) was tailored for expression in E. coli by the primer extension method, previously described for the expression of HuIFN-,8 (32) . An EcoRI fragment (712 bp; 5 pig) of pmcl4 was denatured by heat with 200 pmol of the 5' 32P-labeled synthetic
. This primer was extended in a reaction containing 50 mM NaCl, 6 mM Tris HCl (pH 7.4), 6 mM MgCl2, 6 mM 2-mercaptoethanol, 10 units of the Klenow fragment of E. coli DNA polymerase I, and deoxynucleoside triphosphates, each at 0.5 mM (32) . The reaction proceeded at 370C for 4 hr and then was extracted with phenol/chloroform, and the DNA was ethanol precipitated. The DNA was digested with Pst I (New England BioLabs) and subjected to electrophoresis through a 5% polyacrylamide gel. The primer extension product of 145 bp was identified by autoradiography and isolated by electroelution. This DNA was ligated to a vector used to express IFN-aD (33); the vector, pLeIFDtrpll, was digested with Xba I, filled in with deoxynucleotides and Klenow polymerase, digested with Pst I, and subsequently isolated by gel electrophoresis. The ligation reaction was transformed into E. coli 294, and a tetracycline-resistant colony, pmytrpl, was identified as having the proper construction by restriction endonuclease mapping and DNA sequence determination. The 644-bp Pst I fragment from pmcl4, containing sequences coding for the 3' end of the cDNA, was ligated into the plasmid pmytrpl. The resulting E. coli expression plasmid, pmytrp6, was characterized by sequence analysis of the MuIFN-y coding region. E. coli containing plasmid pmytrp6 were grown in M9 media to an OD&0 of 1.0, harvested by centrifugation, resuspended in phosphate-buffered saline, and sonicated. This extract was diluted and assayed for antiviral activity.
RESULTS
The HuIFN-y cDNA (8) was used as a hybridization probe to screen a recombinant murine-A phage library for the MuIFNy gene. By utilizing low-stringency conditions of hybridization and washing, several hybridizing signals were observed on duplicate filters. Corresponding phage were plaque-purified, and in R "I a. e v i l phage DNA was prepared. The DNA of phage AMG9 contained a 10.5-kbp BamHI fragment that hybridized to both 5' and 3' probes of the HuIFN-^y cDNA (Southern analysis not shown). The 10.5-kbp BamHI fragment was subcloned in pBR322 and was characterized by DNA sequence analysis. The sequence revealed a 6,000-bp stretch of DNA having high homology (60%) to the HuIFN-y gene. (This DNA sequence will be published elsewhere.)
A schematic representation of the MuIFN-y gene structure is seen in Fig. 1 . The MuIFN-y gene has a structure similar to the HuIFN-y gene (9) , containing four exons and three introns. The potential coding regions. of the MuIFN-y gene were determined by homology, comparisons with the human gene. The predicted protein sequence was confirmed by sequence analysis of the cDNA, which ispresented-below. Southern analysis of mouse genomic DNA suggests that there is a single MuIFN-'y gene per haploid genome (data not shown), as observed for the HuIFN-y gene.
To confirm the identity of this DNA sequence as the MuIFNy gene, the DNA was engineered for expression, and the resulting protein was shown to have antiviral activity..As~outlihed in Fig. 1 , a restriction fragment containing the putative-5' coding portion (Pvu I-Cla I, 348 bp) and-a fragment containing the remaining 3' coding sequences (Cla I-Bgl IIX 6,400 bp) were ligated to a SV40-based expression vector, p342E, which'has been shown to efficiently synthesize hepatitis B surface antigen (27) . The resulting MuIFN-y-expression plasmid-was transfected into the monkey-cell'line.COS-1-(28), which endogenously produces T antigen and allows replication of plasmids containing a SV4Q origin of replication. (34, 35) . The transfected cells were grown for 2 days, and then the culture supernatant. was assayed for antiviral activity by using a murine L929'cell assay challenged with encephalomyocarditis virus (19) . Media from transfected COS-1 cells contained 6,000 units per ml of IFN activity, whereas media from nontransfected COS-1 cells contained no detectable activity.
The antiviral activity secreted from transfected COS-1 cells was identified as MuIFN-y both antigenically and biochemically ( Table 1 y gene sequence (9) . Intron-exon splice junctions appear to occur at positions homologous with the HuIFN-y gene (9) . To confirm the coding sequence of MuIFN-y, we isolated and determined the sequence of MuIF-N-y cDNA clones derived from mRNA from pSVEmuy transfected COS cells. In order to further show that this gene is expressed during mitogenic stimulation of lymphocytes, we also isolated a cDNA clone derived from mRNA isolated from concanavalin A-induced murine spleen cultures. The cDNA libraries (3, 200 clones from transfected COS-1 cell mRNA and 6,000 clones from spleen mRNA) were independently screened with a 32P-labeled probe prepared from the 3' end of the gene. Seventeen of the COS-1-derived cDNAclones and a single spleen-derived clone hybridized with the probe. The chemical degradation method of Maxam and Gilbert (25) was used to determine the sequence of the cDNA inserts of one of the COS-1-derived clones, pmcl4, and the spleenderived clone, pmsl0. Both pmcl4.and the shorter pmsl0 contained the entire coding region of the MuIFN-y gene (Fig. 2) .
The MuiIFN-y cDNA (pmcl4) was tailored for expression in E. coli by the primer extension method (32) as described. E. coli 294 harboring the resulting 'MuIFN-y expression plasmid pmytrp6 produced =50,000 units per ml of bacterial culture in the murine antiviral assay. The characteristics of this. activity are presented in Fig. 3 . The overall protein homology is only 40%, in contrast to the higher DNA homology. This low homology may explain the observed strict species specificity of IFN-,y (19) . HuIFN-a has antiviral activity on a variety of other species (19, 33) , including mouse, hamster, bovine, rabbit, and monkey cells. This is reflected in the higher protein homologies Biochemistrv: Gray 
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idues and 15 acidic residues. The-measured isoelectric point of HuIFN-,B which is about 60% homologous with bovine IFNnatural MuIFN-y is between pH 5.5 and 6.0 (4, 5) ; the dis-/3 (unpublished results), has low activity on bovine cells (32) .
crepancy between this value-and the predicted basic nature may MuIFN-y has several structural features similar to HuIFNbe due to sialic -acid residues added during glycosylation. y. Both contain two potential N-glyeosylation sequences-(36), MuIFN-y contains three cysteine residues at positions 1, 3, although at different positions (Fig. 3) . Both proteins contain and 136. HuIFN-y contains only two cysteines at positions 1 'an excess of basic residues, although HuIFN-y is more highly and 3 of the mature protein, which may be too close for the formation of a disulfide bond due to steric hindrance. The MuIFN-y has the potential for an intramolecular disulfide bridge between either of the amino-terminal cysteine residues and position 136. Such a disulfide bond may confer added stability to the molecule, and, indeed, we have observed an increased temperature lability profile of antiviral activity when recombinant MuIFN-y from COS-1 cells (melting temperature tm = 550C) and HuIFN-y (tm = 450C) are compared (unpublished observations). Incubation of HuIFN-y at 55TC for 1 hr totally destroys antiviral activity, but only 50% of MuIFN-y is lost under these conditions. Other investigators have observed this increased thermostability of natural MuIFN-y (5) . Estimated values of the size of natural MuIFN-y range from Mr 38,000 to Mr 80,000 (2, 4, 5) and are based on molecular sieve chromatography. The encoded size of the mature protein based on the DNA sequence is only 15,894. This discrepancy between the observed and predicted sizes is probably due to glycosylation and aggregation. A similar situation was observed with HuIFN-y. The cloned DNA sequence encoded a mature protein of 17,110 (8) ; however, gel filtration had suggested a Mr range of 40,000-70,000 (37) . Two polypeptides containing antiviral activity have been eluted from NaDodSO4/polyacrylamide gels of highly purified natural human IFN-y at Mrs 20,000 and 25,000 (38) . These two forms may differ in their degree of glycosylation and may aggregate to form the observed higher Mr species.
Availability of 'recombinant MuIFN-y will greatly aid the biological studies of IFN-y action. Besides having potent antiviral activity, this molecule may have anticellular activity against transformed cell lines. Furthermore, MuIFN-y may stimulate the immune system; it appears to activate natural killer cell activity (39) and to induce Ia antigen synthesis (40) . These studies were performed with material from mitogen-induced lymphocyte cultures that were not purified to homogeneity; other lymphokines may contaminate these preparations and affect -the observed activities attributed to MuIFN-y. The recombinant MuIFN-y should clarify these results and also provide sufficient material for in vivo studies.
